WALTHAM, Mass.--(BUSINESS WIRE)-- Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (INVA), announced today that two of the company’s infectious disease therapies, ZEVTERA ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results